CREO.L

Creo Medical Limited [CREO.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CREO.L Stock Summary

Top 10 Correlated ETFs

CREO.L


Top 10 Correlated Stocks

CREO.L


In the News

CREO.L Financial details

Company Rating
Neutral
Market Cap
133.35M
Income
-34.97M
Revenue
29.34M
Book val./share
0.26
Cash/share
0.1
Dividend
-
Dividend %
-
Employees
279
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
-3.13
Forward P/E
-3425
PEG
-0.52
P/S
5.96
P/B
1.71
P/C
342.5
P/FCF
-5.73
Quick Ratio
0.75
Current Ratio
1.93
Debt / Equity
0.13
LT Debt / Equity
0.08
-
-
EPS (TTM)
-0.22
EPS next Y
-0.01
EPS next Q
-
EPS this Y
-0%
EPS next Y
-96.88%
EPS next 5Y
-132.99%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
16.03%
EPS Q/Q
-39.42%
-
-
-
-
SMA20
16.13%
SMA50
-16.28%
SMA100
9.09%
Inst Own
-
Inst Trans
-
ROA
-36%
ROE
-44%
ROC
-0.53%
Gross Margin
48%
Oper. Margin
-113%
Profit Margin
-99%
Payout
-
Shs Outstand
361.48M
Shs Float
324.7M
-
-
-
-
Target Price
-
52W Range
22.718-50.0
52W High
-31.5%
52W Low
+55.68%
RSI
41
Rel Volume
0.84
Avg Volume
846.74K
Volume
709.1K
Perf Week
-6.8%
Perf Month
-0.72%
Perf Quarter
-2.84%
Perf Half Y
7.03%
-
-
-
-
Beta
0.839
-
-
Volatility
0.96%, 2.58%
Prev Close
-1.44%
Price
34.25
Change
-2.31%

CREO.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
000.060.150.15
Net income per share
-0.11-0.13-0.13-0.15-0.15
Operating cash flow per share
-0.16-0.09-0.1-0.16-0.14
Free cash flow per share
-0.17-0.1-0.1-0.2-0.16
Cash per share
0.490.640.280.260.07
Book value per share
0.530.660.390.450.27
Tangible book value per share
0.520.650.10.170.01
Share holders equity per share
0.530.660.390.450.27
Interest debt per share
000.070.060.05
Market cap
179.65M227.58M312.9M245.01M45.79M
Enterprise value
135.49M147.25M280.17M212.03M42.79M
P/E ratio
-18.2-14.3-15.4-9.96-1.7
Price to sales ratio
016.89K33.199.741.69
POCF ratio
-12.66-19.72-19.45-9.43-1.83
PFCF ratio
-11.53-17.98-18.78-7.63-1.62
P/B Ratio
3.772.754.983.340.93
PTB ratio
3.772.754.983.340.93
EV to sales
010.93K29.718.431.57
Enterprise value over EBITDA
-11.67-8.01-12.85-7.74-1.54
EV to operating cash flow
-9.54-12.76-17.42-8.16-1.71
EV to free cash flow
-8.69-11.63-16.82-6.6-1.51
Earnings yield
-0.05-0.07-0.06-0.1-0.59
Free cash flow yield
-0.09-0.06-0.05-0.13-0.62
Debt to equity
0.010.010.170.130.18
Debt to assets
0.010.010.120.090.12
Net debt to EBITDA
3.84.371.51.20.11
Current ratio
29.5817.033.33.11.93
Interest coverage
-1.07K-1.35K-241.15-126.41-124.22
Income quality
1.440.730.791.060.93
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
01.41K2.921.651.62
Research and developement to revenue
0604.641.080.510.5
Intangibles to total assets
0.010.010.510.460.63
Capex to operating cash flow
0.10.10.040.240.13
Capex to revenue
0-82.97-0.06-0.24-0.12
Capex to depreciation
-4.19-1.74-0.36-2.39-1.05
Stock based compensation to revenue
0115.40.080.10.05
Graham number
1.141.371.051.220.95
ROIC
-0.21-0.19-0.27-0.29-0.45
Return on tangible assets
-0.2-0.18-0.44-0.45-0.96
Graham Net
0.50.630.150.160
Working capital
46.87M81.04M41.44M41.43M16.2M
Tangible asset value
47.41M81.8M16.01M27.5M2.2M
Net current asset value
46.48M80.49M29.81M33.88M7.75M
Invested capital
0.010.010.170.130.18
Average receivables
03.7M5.71M8.05M9.47M
Average payables
0831.17K1.69M3M3.91M
Average inventory
0514.82K3.77M7.66M8.91M
Days sales outstanding
0110.48K283.86127.06136.68
Days payables outstanding
813.43518.28128.3880.0291.02
Days of inventory on hand
332.93408.17355.65192.34198.35
Receivables turnover
001.292.872.67
Payables turnover
0.450.72.844.564.01
Inventory turnover
1.10.891.031.91.84
ROE
-0.21-0.19-0.32-0.34-0.55
Capex per share
-0.02-0.010-0.04-0.02

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2018-03-312018-06-302018-12-312022-12-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0000.070.06
Net income per share
-0.03-0.05-0.06-0.07-0.04
Operating cash flow per share
-0.02-0.03-0.07-0.05-0.06
Free cash flow per share
-0.02-0.03-0.08-0.06-0.06
Cash per share
00.080.450.070.1
Book value per share
00.090.480.270.26
Tangible book value per share
00.090.480.010.09
Share holders equity per share
00.090.480.270.26
Interest debt per share
00.0100.050.03
Market cap
91.73M100.39M198.18M45.8M93.27M
Enterprise value
094.47M153.59M42.8M90.97M
P/E ratio
-10.91-5.82-8.91-0.85-2.01
Price to sales ratio
0956.0958.84K3.385.94
POCF ratio
-52.45-38.52-28.61-4.99-6.26
PFCF ratio
-46.79-37.31-26.2-4.36-6.06
P/B Ratio
013.74.150.931.35
PTB ratio
013.74.150.931.35
EV to sales
0899.7445.6K3.165.79
Enterprise value over EBITDA
0-18.9-23.81-3.25-7.78
EV to operating cash flow
0-36.25-22.17-4.67-6.11
EV to free cash flow
0-35.11-20.3-4.07-5.91
Earnings yield
-0.02-0.04-0.03-0.29-0.12
Free cash flow yield
-0.02-0.03-0.04-0.23-0.17
Debt to equity
00.060.010.180.13
Debt to assets
00.050.010.120.1
Net debt to EBITDA
01.186.910.230.2
Current ratio
04.6529.581.934.13
Interest coverage
-1.35K-2.72K-1.88K-71.38-134
Income quality
0.830.61.250.681.28
Dividend Yield
00000
Payout ratio
0-0.02000
Sales general and administrative to revenue
050.461.98K1.581.33
Research and developement to revenue
021.9870.120.450
Intangibles to total assets
000.010.630.51
Capex to operating cash flow
0.120.030.090.150.03
Capex to revenue
0-0.81-189.26-0.1-0.03
Capex to depreciation
-2.73-0.47-4.32-0.81-0.29
Stock based compensation to revenue
04.86205.810.050.04
Graham number
00.330.770.680.5
ROIC
0-0.78-0.16-0.23-0.15
Return on tangible assets
0-0.45-0.11-0.48-0.27
Graham Net
00.060.4300.08
Working capital
06.87M46.87M16.2M37.2M
Tangible asset value
07.32M47.41M2.2M23.7M
Net current asset value
06.46M46.48M7.75M29.4M
Invested capital
00.060.010.180.13
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
0558.05067.6783.69
Days payables outstanding
0031.22K93.8868.18
Days of inventory on hand
0012.78K97.2772.73
Receivables turnover
00.1601.331.08
Payables turnover
0000.961.32
Inventory turnover
000.010.931.24
ROE
0-0.59-0.12-0.27-0.17
Capex per share
00-0.01-0.010

CREO.L Frequently Asked Questions

What is Creo Medical Limited stock symbol ?

Creo Medical Limited is a GB stock and trading under the symbol CREO.L

What is Creo Medical Limited stock quote today ?

Creo Medical Limited stock price is $34.25 today.

Is Creo Medical Limited stock public?

Yes, Creo Medical Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap